Dipotassium Clorazepate Monohydrate is a benzodiazepine derivative used as an active pharmaceutical ingredient (API) with anxiolytic, anticonvulsant, sedative, and muscle-relaxant properties. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Transilium and Tranxilium. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 23706210.
Dipotassium clorazepate monohydrate
| CAS No | 57109-90-7 |
|---|---|
| Molecular Formula | C16H11ClK2N2O4 |
| Molecular Weight | 408.92 g/mol |
| Synonyms | dipotassium;7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylate;hydroxide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dipotassium Clorazepate Monohydrate is a benzodiazepine derivative used as an active pharmaceutical ingredient (API) with anxiolytic, anticonvulsant, sedative, and muscle-relaxant properties.
The listed CAS number is 57109-90-7.
The listed molecular formula is C16H11ClK2N2O4.
The listed molecular weight is 408.92 g/mol.
dipotassium;7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylate;hydroxide.
The source lists Transilium and Tranxilium.